Where can I find news about NURPF?

The latest headlines, third-party analysis, and SEC filings for Neuren Pharmaceuticals Limited (NURPF) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are NURPF's SEC filings?

Neuren Pharmaceuticals Limited (NURPF)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are NURPF's earnings call transcripts?

Full earnings call transcripts for Neuren Pharmaceuticals Limited (NURPF) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

NURPF

Neuren Pharmaceuticals Limited

OTC·Biotechnology · Healthcare

$15.51$0.00+0.00%

Market cap$1.97B·Market closed·Aug 25 8:00 PM UTC

News & Analysis

Neuren Pharmaceuticals Limited (NURPF) Q2 2026 Earnings Call Transcript
Neuren Pharmaceuticals Limited (NURPF) Q2 2026 Earnings Call Transcript
seekingalpha.comAug 26, 2026 · 3:19 AM
Hyperion DeFi (NASDAQ:HYPD) versus Neuren Pharmaceuticals (OTCMKTS:NURPF) Critical Survey
Hyperion DeFi (NASDAQ: HYPD - Get Free Report) and Neuren Pharmaceuticals (OTCMKTS:NURPF - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk. Valuation and Earnings This table compares Hyperion DeFi
defenseworld.netApr 7, 2026 · 1:56 AM
Neuren Pharmaceuticals (OTCMKTS:NURPF) Stock Price Down 13.5% – Should You Sell?
Shares of Neuren Pharmaceuticals Limited (OTCMKTS:NURPF - Get Free Report) were down 13.5% during mid-day trading on Monday. The company traded as low as C$8.53 and last traded at C$8.53. Approximately 2,010 shares were traded during trading, an increase of 104% from the average daily volume of 987 shares. The stock had previously closed
defenseworld.netFeb 24, 2026 · 2:58 AM
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript
seekingalpha.comFeb 12, 2026 · 3:14 AM

SEC Filings

No recent filings indexed.

Frequently Asked Questions About NURPF

Where can I find news about NURPF?: The latest headlines, third-party analysis, and SEC filings for Neuren Pharmaceuticals Limited (NURPF) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are NURPF's SEC filings?: Neuren Pharmaceuticals Limited (NURPF)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are NURPF's earnings call transcripts?: Full earnings call transcripts for Neuren Pharmaceuticals Limited (NURPF) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

Neuren Pharmaceuticals Limited

Frequently Asked Questions About NURPF

Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited (NURPF) Q2 2026 Earnings Call Transcript

Hyperion DeFi (NASDAQ:HYPD) versus Neuren Pharmaceuticals (OTCMKTS:NURPF) Critical Survey

Neuren Pharmaceuticals (OTCMKTS:NURPF) Stock Price Down 13.5% – Should You Sell?

Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript

Frequently Asked Questions About NURPF

Neuren Pharmaceuticals Limited (NURPF) Q2 2026 Earnings Call Transcript

Hyperion DeFi (NASDAQ:HYPD) versus Neuren Pharmaceuticals (OTCMKTS:NURPF) Critical Survey

Neuren Pharmaceuticals (OTCMKTS:NURPF) Stock Price Down 13.5% – Should You Sell?

Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript